Cargando…

Thromboxane A(2) exacerbates acute lung injury via promoting edema formation

Thromboxane A(2) (TXA(2)) is produced in the lungs of patients suffering from acute lung injury (ALI). We assessed its contribution in disease progression using three different ALI mouse models. The administration of hydrochloric acid (HCl) or oleic acid (OA)+ lipopolysaccharide (LPS) caused tissue...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Koji, Horikami, Daiki, Omori, Keisuke, Nakamura, Tatsuro, Yamazaki, Arisa, Maeda, Shingo, Murata, Takahisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999811/
https://www.ncbi.nlm.nih.gov/pubmed/27562142
http://dx.doi.org/10.1038/srep32109
_version_ 1782450164587298816
author Kobayashi, Koji
Horikami, Daiki
Omori, Keisuke
Nakamura, Tatsuro
Yamazaki, Arisa
Maeda, Shingo
Murata, Takahisa
author_facet Kobayashi, Koji
Horikami, Daiki
Omori, Keisuke
Nakamura, Tatsuro
Yamazaki, Arisa
Maeda, Shingo
Murata, Takahisa
author_sort Kobayashi, Koji
collection PubMed
description Thromboxane A(2) (TXA(2)) is produced in the lungs of patients suffering from acute lung injury (ALI). We assessed its contribution in disease progression using three different ALI mouse models. The administration of hydrochloric acid (HCl) or oleic acid (OA)+ lipopolysaccharide (LPS) caused tissue edema and neutrophil infiltration with TXA(2) production in the lungs of the experimental mice. The administration of LPS induced only neutrophil accumulation without TXA(2) production. Pretreatment with T prostanoid receptor (TP) antagonist attenuated the tissue edema but not neutrophil infiltration in these models. Intravital imaging and immunostaining demonstrated that administration of TP agonist caused vascular hyper-permeability by disrupting the endothelial barrier formation in the mouse ear. In vitro experiments showed that TP-stimulation disrupted the endothelial adherens junction, and it was inhibited by Ca(2+) channel blockade or Rho kinase inhibition. Thus endogenous TXA(2) exacerbates ALI, and its blockade attenuates it by modulating the extent of lung edema. This can be explained by the endothelial hyper-permeability caused by the activation of TXA(2)-TP axis, via Ca(2+)- and Rho kinase-dependent signaling.
format Online
Article
Text
id pubmed-4999811
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-49998112016-09-01 Thromboxane A(2) exacerbates acute lung injury via promoting edema formation Kobayashi, Koji Horikami, Daiki Omori, Keisuke Nakamura, Tatsuro Yamazaki, Arisa Maeda, Shingo Murata, Takahisa Sci Rep Article Thromboxane A(2) (TXA(2)) is produced in the lungs of patients suffering from acute lung injury (ALI). We assessed its contribution in disease progression using three different ALI mouse models. The administration of hydrochloric acid (HCl) or oleic acid (OA)+ lipopolysaccharide (LPS) caused tissue edema and neutrophil infiltration with TXA(2) production in the lungs of the experimental mice. The administration of LPS induced only neutrophil accumulation without TXA(2) production. Pretreatment with T prostanoid receptor (TP) antagonist attenuated the tissue edema but not neutrophil infiltration in these models. Intravital imaging and immunostaining demonstrated that administration of TP agonist caused vascular hyper-permeability by disrupting the endothelial barrier formation in the mouse ear. In vitro experiments showed that TP-stimulation disrupted the endothelial adherens junction, and it was inhibited by Ca(2+) channel blockade or Rho kinase inhibition. Thus endogenous TXA(2) exacerbates ALI, and its blockade attenuates it by modulating the extent of lung edema. This can be explained by the endothelial hyper-permeability caused by the activation of TXA(2)-TP axis, via Ca(2+)- and Rho kinase-dependent signaling. Nature Publishing Group 2016-08-26 /pmc/articles/PMC4999811/ /pubmed/27562142 http://dx.doi.org/10.1038/srep32109 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Kobayashi, Koji
Horikami, Daiki
Omori, Keisuke
Nakamura, Tatsuro
Yamazaki, Arisa
Maeda, Shingo
Murata, Takahisa
Thromboxane A(2) exacerbates acute lung injury via promoting edema formation
title Thromboxane A(2) exacerbates acute lung injury via promoting edema formation
title_full Thromboxane A(2) exacerbates acute lung injury via promoting edema formation
title_fullStr Thromboxane A(2) exacerbates acute lung injury via promoting edema formation
title_full_unstemmed Thromboxane A(2) exacerbates acute lung injury via promoting edema formation
title_short Thromboxane A(2) exacerbates acute lung injury via promoting edema formation
title_sort thromboxane a(2) exacerbates acute lung injury via promoting edema formation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999811/
https://www.ncbi.nlm.nih.gov/pubmed/27562142
http://dx.doi.org/10.1038/srep32109
work_keys_str_mv AT kobayashikoji thromboxanea2exacerbatesacutelunginjuryviapromotingedemaformation
AT horikamidaiki thromboxanea2exacerbatesacutelunginjuryviapromotingedemaformation
AT omorikeisuke thromboxanea2exacerbatesacutelunginjuryviapromotingedemaformation
AT nakamuratatsuro thromboxanea2exacerbatesacutelunginjuryviapromotingedemaformation
AT yamazakiarisa thromboxanea2exacerbatesacutelunginjuryviapromotingedemaformation
AT maedashingo thromboxanea2exacerbatesacutelunginjuryviapromotingedemaformation
AT muratatakahisa thromboxanea2exacerbatesacutelunginjuryviapromotingedemaformation